GLP-3, as a triple agonist targeting GLP-1, GIP, and GCG receptors, holds significant promise as a research compound in the investigation of type 2 diabetesnot only through its observed influence on glycemic parameters but also via its substantial impact on weight reduction
Frequently Asked Questions About Peptide Dosing How do I convert mg to mcg in peptides
However, if you or your family have a history of pancreas issues, it might be wise to avoid the drug class altogether
Factors such as individual metabolism, overall health, and concurrent medications can all influence how one experiences fatigue while on GLP-1 therapy
Rather than semaglutide, for instance, they might use semaglutide sodium, which is a version of the drug that has a sodium salt attached
For people with a condition called extreme obesity (a BMI of 40+) or obesity plus a weight-related condition like type 2 diabetes or high blood pressure, bariatric surgery may be an option